Efficacy and safety of hepatic arterial infusion chemotherapy plus lenvatinib and PD-1/PD-L1 inhibitors versus systemic chemotherapy plus lenvatinib and PD-1/PD-L1 inhibitors in advanced unresectable cholangiocarcinoma: a retrospective cohort study

Abstract Background Hepatic arterial infusion chemotherapy (HAIC) provides sustained high intrahepatic drug exposure with limited systemic toxicity, potentially enhancing antigen release and immune sensitization. This study compared the efficacy and safety of HAIC combined with lenvatinib and PD-1/P...

وصف كامل

التفاصيل البيبلوغرافية

المؤلفون الرئيسيون:	Zhenzhen Zhang, Meixia Wang, Guobin Chen, Yanfang Wu, Xiaochun Chen, Xinkun Guo, Boheng Zhang
التنسيق:	Artigo
اللغة:	Inglês
منشور في:	Springer 2025-12-01
سلاسل:	Cancer Immunology, Immunotherapy
الموضوعات:	Intrahepatic cholangiocarcinoma HAIC Lenvatinib PD-1/PD-L1 inhibitor Survival Biomarkers
الوصول للمادة أونلاين:	https://doi.org/10.1007/s00262-025-04255-1
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!